These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 15110900

  • 1. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T, Dusek J, Vondrák K, Flögelová H, Geier P, Janda J.
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [Abstract] [Full Text] [Related]

  • 2. Ramipril in the treatment of proteinuria in children after renal transplantation.
    Seeman T, Dusek J, Vondrák K, Janda J.
    Pediatr Transplant; 2010 Mar; 14(2):283-7. PubMed ID: 19686445
    [Abstract] [Full Text] [Related]

  • 3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D, Moritz ML, Vats A, Janosky JE.
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [Abstract] [Full Text] [Related]

  • 5. Strict blood-pressure control and progression of renal failure in children.
    ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.
    N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849
    [Abstract] [Full Text] [Related]

  • 6. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.
    Am J Kidney Dis; 2007 Dec 22; 50(6):908-17. PubMed ID: 18037091
    [Abstract] [Full Text] [Related]

  • 7. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D, Vats A, Moritz ML, Reitz S, Grosso MJ, Janosky JE.
    J Pediatr; 2003 Jul 22; 143(1):89-97. PubMed ID: 12915830
    [Abstract] [Full Text] [Related]

  • 8. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J, Lüders S, Kulschewski A, Hammersen F, Züchner C, Venneklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W, MARPLE Study Group.
    J Hypertens; 2006 Mar 22; 24(3):541-8. PubMed ID: 16467658
    [Abstract] [Full Text] [Related]

  • 9. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 22; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.
    Wühl E, Mehls O, Schaefer F, ESCAPE Trial Group.
    Kidney Int; 2004 Aug 22; 66(2):768-76. PubMed ID: 15253732
    [Abstract] [Full Text] [Related]

  • 11. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M.
    Am J Hypertens; 2004 Jun 22; 17(6):495-501. PubMed ID: 15177521
    [Abstract] [Full Text] [Related]

  • 12. Reduction of proteinuria during intensified antihypertensive therapy in children after renal transplantation.
    Seeman T, Simková E, Kreisinger J, Vondrák K, Dusek J, Dvorák P, Stuchlikova H, Janda J.
    Transplant Proc; 2007 Dec 22; 39(10):3150-2. PubMed ID: 18089341
    [Abstract] [Full Text] [Related]

  • 13. Long-term control of ambulatory hypertension in children: improving with time but still not achieving new blood pressure goals.
    Seeman T, Gilík J.
    Am J Hypertens; 2013 Jul 22; 26(7):939-45. PubMed ID: 23645323
    [Abstract] [Full Text] [Related]

  • 14. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.
    Seeman T, Gilík J, Vondrák K, Simková E, Flögelová H, Hladíková M, Janda J.
    Am J Hypertens; 2007 Sep 22; 20(9):990-6. PubMed ID: 17765141
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T, Pohl M, Misselwitz J, John U.
    Kidney Blood Press Res; 2009 Sep 22; 32(6):440-4. PubMed ID: 20016211
    [Abstract] [Full Text] [Related]

  • 16. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Sep 22; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 17. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB, Cleveland JM, Rolleri RL, Ramipril-Hydrochlorothiazide Study Group.
    J Hum Hypertens; 2008 Aug 22; 22(8):559-68. PubMed ID: 18463672
    [Abstract] [Full Text] [Related]

  • 18. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H, Hayashi K, Saruta T.
    J Hum Hypertens; 2003 Apr 22; 17(4):271-6. PubMed ID: 12692572
    [Abstract] [Full Text] [Related]

  • 19. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug 22; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 20. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM, Berger ED, Heyne N, Klass M, Krämer D, Braun N, Wolf S, Risler T.
    Dtsch Med Wochenschr; 1997 Aug 01; 122(31-32):953-8. PubMed ID: 9280714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.